Showing 5716 results

  • Workforce education resources

    • 28 March 2024
    • Content pages
    TURAs contains vaccine specific training resources for registered healthcare practitioners relating to Mpox. Access TURAS for resources on vaccination against mpox using MVA-BN...
  • Pre and post-exposure vaccination

    • 28 March 2024
    • Content pages
    Read the following resources. CMO letter of 18 July 2022 with information on pre- and post-exposure vaccination for mpox in Scotland. UKSHA guidance on mpox vaccination...
  • Informing PHS and requesting the vaccine

    • 28 March 2024
    • Content pages
    We provide information for local health protection teams about how to: inform PHS following public health assessment request the vaccine View the process for informing PHS (SHPIR...
  • Leaflets for the public

    • 28 March 2024
    • Content pages
    Download our protect yourself against mpox leaflet for use with the public. ...
  • Public health management of HCID and non-HCID mpox cases

    • 28 March 2024
    • Content pages
    Our PHS guidance for health protection teams (HPTs) is based on the UK Health Security Agency (UKHSA) guidance and distinguishes actions for HCID and non HCID strains. Read our PHS...
  • Enhanced surveillance of mpox

    • 28 March 2024
    • Content pages
    Enhanced surveillance data is being coordinated by devolved administrations and submitted centrally to a UK mpox database at UKHSA. For confirmed cases, submit an enhanced...
  • Infection control guidance

    • 28 March 2024
    • Content pages
    The following infection control guidance is available. ARHAI guidance on infection prevention and control in healthcare settings. PHS guidance on cleaning sex-on-premises...
  • Laboratory guidance

    • 28 March 2024
    • Content pages
    View our laboratory information note on mpox cases in the UK. ...
  • What is mpox?

    • 28 March 2024
    • Content pages
    Mpox is a rare infection in the UK. Two clades of mpox are recognised – Clade I and Clade II. Clade I is considered a high consequence infectious disease (HCID) while Clade II is...
  • Name change

    • 28 March 2024
    • Content pages
    The World Health Organization (WHO) has recommended that 'monkeypox' should now be referred to as 'mpox'. The name change is to address concerns around stigmatising language...